Tricida, Inc. Logo

Tricida, Inc.

TCDA

(2.2)
Stock Price

0,11 USD

-115.23% ROA

-355.98% ROE

-0.03x PER

Market Cap.

5.952.334,00 USD

64928.44% DER

0% Yield

0% NPM

Tricida, Inc. Stock Analysis

Tricida, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Tricida, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (79.85%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 PBV

With a remarkably low PBV ratio (-0.05x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a minimal amount of debt (-153%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Revenue Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

5 Net Profit Growth

This company's net profit has been consistently on the rise over the past three years, indicating a strong financial performance and making it an appealing investment opportunity.

6 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

7 ROA

The stock's ROA (-95.72%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Tricida, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Tricida, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Sell
4 Stoch RSI Hold

Tricida, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Tricida, Inc. Revenue
Year Revenue Growth
2016 0
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Tricida, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2016 21.820.000
2017 35.906.000 39.23%
2018 85.594.000 58.05%
2019 133.028.000 35.66%
2020 148.417.000 10.37%
2021 115.364.000 -28.65%
2022 79.740.000 -44.68%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Tricida, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2016 5.363.000
2017 11.216.000 52.18%
2018 18.001.000 37.69%
2019 45.796.000 60.69%
2020 102.983.000 55.53%
2021 37.590.000 -173.96%
2022 16.500.000 -127.82%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Tricida, Inc. EBITDA
Year EBITDA Growth
2016 -28.227.000
2017 -40.955.000 31.08%
2018 -102.190.000 59.92%
2019 -169.440.000 39.69%
2020 -245.487.000 30.98%
2021 -158.522.000 -54.86%
2022 -94.840.000 -67.15%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Tricida, Inc. Gross Profit
Year Gross Profit Growth
2016 0
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Tricida, Inc. Net Profit
Year Net Profit Growth
2016 -28.651.000
2017 -41.290.000 30.61%
2018 -102.808.000 59.84%
2019 -176.813.000 41.85%
2020 -264.791.000 33.23%
2021 -194.168.000 -36.37%
2022 -110.956.000 -75%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Tricida, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2016 -4
2017 -8 42.86%
2018 -5 -75%
2019 -4 -33.33%
2020 -5 40%
2021 -4 -66.67%
2022 -2 -200%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Tricida, Inc. Free Cashflow
Year Free Cashflow Growth
2016 -23.364.000
2017 -41.405.000 43.57%
2018 -95.711.000 56.74%
2019 -131.013.000 26.95%
2020 -232.792.000 43.72%
2021 -140.155.000 -66.1%
2022 -18.750.000 -647.49%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Tricida, Inc. Operating Cashflow
Year Operating Cashflow Growth
2016 -23.115.000
2017 -40.401.000 42.79%
2018 -94.856.000 57.41%
2019 -129.590.000 26.8%
2020 -231.187.000 43.95%
2021 -140.056.000 -65.07%
2022 -18.747.000 -647.08%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Tricida, Inc. Capital Expenditure
Year Capital Expenditure Growth
2016 249.000
2017 1.004.000 75.2%
2018 855.000 -17.43%
2019 1.423.000 39.92%
2020 1.605.000 11.34%
2021 99.000 -1521.21%
2022 3.000 -3200%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Tricida, Inc. Equity
Year Equity Growth
2016 -47.628.000
2017 59.219.000 180.43%
2018 194.525.000 69.56%
2019 263.883.000 26.28%
2020 108.871.000 -142.38%
2021 218.000 -49840.83%
2022 -136.098.000 100.16%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Tricida, Inc. Assets
Year Assets Growth
2016 27.684.000
2017 70.658.000 60.82%
2018 247.849.000 71.49%
2019 371.826.000 33.34%
2020 315.127.000 -17.99%
2021 168.506.000 -87.01%
2022 93.879.000 -79.49%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Tricida, Inc. Liabilities
Year Liabilities Growth
2016 75.312.000
2017 11.439.000 -558.38%
2018 53.324.000 78.55%
2019 107.943.000 50.6%
2020 242.814.000 55.54%
2021 168.288.000 -44.28%
2022 229.977.000 26.82%

Tricida, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-3.88
Price to Earning Ratio
-0.03x
Price To Sales Ratio
0x
POCF Ratio
-0.04
PFCF Ratio
-0.04
Price to Book Ratio
24.78
EV to Sales
0
EV Over EBITDA
-0.8
EV to Operating CashFlow
-0.9
EV to FreeCashFlow
-0.9
Earnings Yield
-35.94
FreeCashFlow Yield
-23.55
Market Cap
0,01 Bil.
Enterprise Value
0,13 Bil.
Graham Number
0.62
Graham NetNet
-0.55

Income Statement Metrics

Net Income per Share
-3.88
Income Quality
0.79
ROE
-3.56
Return On Assets
-1.15
Return On Capital Employed
-1.14
Net Income per EBT
1.1
EBT Per Ebit
1.11
Ebit per Revenue
0
Effective Tax Rate
-0.1

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-2.8
Free CashFlow per Share
-2.8
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
-0.22
Return on Invested Capital
-1.12
Return on Tangible Assets
-1.15
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
-0

Balance Sheet

Cash per Share
2,81
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
3.18
Debt to Equity
649.28
Debt to Assets
0.84
Net Debt to EBITDA
-0.76
Current Ratio
4.94
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
-0,02 Bil.
Invested Capital
649.28
Working Capital
0,12 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,01 Bil.
Average Inventory
0
Debt to Market Cap
23.78

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Tricida, Inc. Dividends
Year Dividends Growth

Tricida, Inc. Profile

About Tricida, Inc.

Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

CEO
Dr. Gerrit Klaerner Ph.D.
Employee
57
Address
7000 Shoreline Court
South San Francisco, 94080

Tricida, Inc. Executives & BODs

Tricida, Inc. Executives & BODs
# Name Age
1 Mr. Edward J. Hejlek Esq., J.D.
Executive Vice President of Intellectual Property
70
2 Mr. Geoffrey M. Parker
Chief Operating Officer, Chief Financial Officer & Executive Vice President
70
3 Mr. Robert L. McKague J.D.
Executive Vice President, Company Sec., Gen. Counsel & Chief Compliance Officer
70
4 Jackie Cossmon
Vice President of Investor Relations & Communications
70
5 Dr. Dawn Parsell Ph.D.
Executive Vice President of Clinical Devel.
70
6 Dr. Gerrit Klaerner Ph.D.
Founder, Pres, Chief Executive Officer & Executive Director
70
7 Ms. Annie Yoshiyama
Vice President of Fin. & Chief Accounting Officer
70

Tricida, Inc. Competitors